What does proceeds from contributed capital mean?

Represents cash inflows resulting from capital contributions made by owners or shareholders to the entity. This metric tracks the direct infusion of equity capital into the business, distinct from operational earnings. It is a key indicator of shareholder support and the company's ability to raise funds to support its strategic objectives.

Tango Therapeutics TNGX Proceeds From Contributed Capital

Proceeds From Contributed Capital at other companies

Amentum HoldingsAMTM

$0-100%

Tango TherapeuticsTNGX

$172.25K—

GHC

Graham HoldingsGHC

$190K+25.8%

ChewyCHWY

$0—

PopularBPOP

$1.82M+3.0%

PopularBPOP

$1.82M+3.0%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Enterprise value$4.43B+2,204%

P/S79.9×+74.4×

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromContributedCapital.

The official record: Tango Therapeutics’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's proceeds from contributed capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's proceeds from contributed capital?: Tango Therapeutics (TNGX) reported proceeds from contributed capital of $172.25K in Q4 2023.
What does proceeds from contributed capital mean?: Represents cash inflows resulting from capital contributions made by owners or shareholders to the entity. This metric tracks the direct infusion of equity capital into the business, distinct from operational earnings. It is a key indicator of shareholder support and the company's ability to raise funds to support its strategic objectives.